News

Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...
MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...
A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Weighty issue
Concerns over new age weight loss, diabetes drugs ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.